+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mannkind Corporation - logo

MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.

Global Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Forecast 2023-2030 - Product Thumbnail Image

Global Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Forecast 2023-2030

  • Report
  • March 2024
  • 196 Pages
  • Global
From
Endocannabinoid System Targeted Therapeutics Market, 2020-2030 - Product Thumbnail Image

Endocannabinoid System Targeted Therapeutics Market, 2020-2030

  • Report
  • April 2020
  • 280 Pages
  • Global
From
Dry Powder Inhaler Devices - Global Market Insights, Competitive Landscape and Market Forecast to 2027 - Product Thumbnail Image

Dry Powder Inhaler Devices - Global Market Insights, Competitive Landscape and Market Forecast to 2027

  • Report
  • October 2022
  • 100 Pages
  • Global
From
Global Continuous Subcutaneous Insulin Infusion Market by Product (Patch Pumps, Tethered Pumps), Patient Type (Type 1 Diabetes, Type 2 Diabetes), End-user - Forecast 2024-2030 - Product Thumbnail Image

Global Continuous Subcutaneous Insulin Infusion Market by Product (Patch Pumps, Tethered Pumps), Patient Type (Type 1 Diabetes, Type 2 Diabetes), End-user - Forecast 2024-2030

  • Report
  • March 2024
  • 182 Pages
  • Global
From
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 733 Pages
  • Global
From
Global Human Insulin Drugs Market by Insulin Type (Basal or Long-Acting Insulins, Biosimilar Insulins, Intermediate-Acting Insulin), Delivery Devices (Insulin Pens, Insulin Pumps, Insulin Syringes), Application, Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Human Insulin Drugs Market by Insulin Type (Basal or Long-Acting Insulins, Biosimilar Insulins, Intermediate-Acting Insulin), Delivery Devices (Insulin Pens, Insulin Pumps, Insulin Syringes), Application, Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 192 Pages
  • Global
From
Next Generation Diabetes Therapy and Drug Delivery Market By Product, By Demographic, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030 - Product Thumbnail Image

Next Generation Diabetes Therapy and Drug Delivery Market By Product, By Demographic, By Indication, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • Report
  • March 2022
  • 254 Pages
  • Global
From
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 135 Pages
  • Global
From
Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 133 Pages
  • Global
From
Human Insulin Drugs Market in Brazil 2024-2028 - Product Thumbnail Image

Human Insulin Drugs Market in Brazil 2024-2028

  • Report
  • December 2023
  • 142 Pages
  • Brazil
From
United States Insulin Delivery Devices Market Size, Analysis, Insights, Trends, Share Outlook, Opportunities, Companies and Forecasts up to 2027 - Product Thumbnail Image

United States Insulin Delivery Devices Market Size, Analysis, Insights, Trends, Share Outlook, Opportunities, Companies and Forecasts up to 2027

  • Report
  • October 2021
  • 180 Pages
  • United States
From
Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • May 2022
  • 156 Pages
  • Global
From
Human Insulin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Human Insulin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 144 Pages
  • Global
From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 Pages
  • Global
From
Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
TYVASO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TYVASO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Global Rapid Acting Insulin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Global Rapid Acting Insulin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • November 2023
  • 141 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Global Insulin Delivery Devices Market Outlook, 2028 - Product Thumbnail Image

Global Insulin Delivery Devices Market Outlook, 2028

  • Report
  • November 2023
  • 190 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Loading Indicator